SWEDISH ORPHAN BIOVITRUM A/S: Financial statements 2012
CVR: 19179079
Source: annual report 2012, Danish Business Authority
01/01/2012 – 31/12/2012
SWEDISH ORPHAN BIOVITRUM A/S (CVR 19179079) has filed annual accounts for 2012. In 2012, the company reported revenue of DKK 22,088,115 and a net result of DKK 580,420. The profit margin was 2.6%. Equity in the 2012 report amounted to DKK 1,080,420. The solvency ratio was 25.8%.
- Revenue
- DKK 22,088,115
- Gross Profit
- DKK 15,504,141
- Profit/Loss
- DKK 580,420
- Equity
- DKK 1,080,420
- Total Assets
- DKK 4,184,782
Official annual report
Keep an eye on SWEDISH ORPHAN BIOVITRUM A/S
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2012
As of June 11, 2012, Alan Henry Raffensperger has joined the board of directors of SWEDISH ORPHAN BIOVITRUM A/S.
As of June 11, 2012, Per Anders Edvell has left the board of directors of SWEDISH ORPHAN BIOVITRUM A/S.
About SWEDISH ORPHAN BIOVITRUM A/S
SWEDISH ORPHAN BIOVITRUM A/S is a Danish company of the type Aktieselskab based in Kgs.Lyngby, founded in 1996. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The company was previously named SWEDISH ORPHAN A/S and ORPHAN DENMARK A/S. The management consists of Bjørn Gustaf Östen Berglund. The board consists of Bjørn Gustaf Östen Berglund, Karl Henrik Stenqvist and Soufiane Fahmy. The company is owned by Swedish Orphan Biovitrum International AB. The company has 9 employees (2026). In 2025, the company reported a gross profit of DKK 18,017,697 and a net result of DKK 3,269,269 compared with DKK 4,570,202 the year before. Equity in the 2025 report amounted to DKK 39,495,805.
